An overview of conceptual frameworks, analytical approaches of the Opioids market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. Opioids market is expected to grow with significant rate in the near future.
The global Opioids Market in 2020 is estimated for more than US$ 19.5 Bn and expected to reach a value of US$ 26.3 Bn by 2028 with a significant CAGR of 3.9%.
Opioids Market Definition
Pain is the major concern currently that is affecting a large chunk of the global population and eventually leading to adopt various drug therapies that have numerous side effects on the body. Opioids in this are helpful though they have a tendency to trigger addiction of its products that had forced the government to keep an eye on their manufacturing and selling.
In 2013, according to The American Academy of Pain Medicine, around 100 Mn people were suffering from pain, which costs around half Tn USD. In past, there had been visible changes in the policies of various healthcare professionals, regulators and public that has positively affected the provision of better pain therapy offerings in the country. Centers for Disease Control and Prevention (CDC) has taken initiatives and provided the customers with a set of guidelines, which possibly be effective for better use of the opioids in the market over the forecast period.
Opioids Market Dynamics
The rapid need of treatment and attaining instant relief are the two major factors that are expected to favor the growth in the opioids market in the near future. Due to the enormous increase in the number of emergency situations along with chronic diseases there has been increasing demand for more types of opioids that help in pain relief. Along with the increase in healthcare facilities and increase in research and development activity in the field of pain management the awareness of the positive effects of opioids has been increased that is expected to support the rise in traction in opioids market in the near future.
Opioids Market Key Players
Global opioids market is mainly dominated by:
Pfizer Inc.
Purdue Pharma
Boehringer Ingelheim
Janssen Pharmaceuticals, Inc.
Actavis Plc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Mallinckrodt Pharmaceuticals
Endo Pharmaceuticals Inc.
Egalet
Opioids Market Segmentation
The global opioids market is segmented on the basis of product type, application type, and region
On the basis of product type, the global opioids market can be segmented into:
Codeine
Meperidine
Methadone
Morphine
Hydrocodone
Fentanyl
On the basis of therapeutic application, the global opioids market can be segmented into:
Pain Management
Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others
Cough Treatment
Diarrhea Treatment
The global opioids market is expected to increase at a significant CAGR over the forecast period owing to the increasing chronic diseases, geriatric population and increase in trend for immediate relief across the healthcare receivers.
Opioids Market Regional Segmentation Overview
On the basis of region, the global opioids market is segmented into six regions namely North America, Latin America, Asia Pacific, Europe, Middle East, and Africa. North America opioids market is expected to be the most dominating market throughout the forecast period. Availability of key players and increasing healthcare expenditure in the region are some of the revenue boosting factors.
MMC Overview on Opioids Market Report
The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.
A research report on the Opioids market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.
Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market. The report is titled as ‘Opioids Market: Opportunity Analysis and Future Assessment 2020-2028’.
Factors that are benchmarked while estimating the market
Various factors that are benchmarked while estimating the market growth includes (but not restricted to):
• New product designs and launches
• Current product compliance
• Reimbursement
• Concerns for use of Opioids
• Advantages of Opioids
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.
A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.
1. Global Opioids Market Report Overview
1.1. Introduction
1.2. Report Description
1.3. Methodology
2. Global Opioids Market Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Executive Summary
2.3. Global Opioids Market Snapshot
2.4. Global Opioids Market Size and Forecast, 2019–2027
2.4.1. Introduction
2.4.2. Market Value Forecast and Annual Growth Rate (AGR) Comparison (2019–2027)
2.5. Global Opioids Market Dynamics
2.5.1. Drivers
2.5.2. Restraints
2.5.3. Opportunity
2.5.4. Trends
2.6. Key Regulations
2.7. Porter’s Five Forces Model
3. Global Opioids Market, By Product Type
3.1. Introduction
3.1.1. Annual Growth Rate Comparison, By Product Type
3.1.2. BPS Analysis, By Product Type
3.2. Market Revenue (US$Mn) Forecast, By Product Type
3.2.1. Codeine
3.2.2. Fentanyl
3.2.3. Meperidine
3.2.4. Methadone
3.2.5. Morphine
3.2.6. Hydrocodone
3.3. Global Opioids Market Attractiveness Index, By Product Type
4. Global Opioids Market, By Therapeutic Application
4.1. Introduction
4.1.1. Annual Growth Rate Comparison, By Therapeutic Application
4.1.2. BPS Analysis, By Therapeutic Application
4.2. Market Revenue (US$Mn) Forecast, By Therapeutic Application
4.2.1. Pain Management
4.2.1.1. Neuropathic Pain
4.2.1.2. Migraine
4.2.1.3. Back Pain
4.2.1.4. Osteoarthritis Pain
4.2.1.5. Cancer Pain
4.2.1.6. Others
4.2.2. Cough Treatment
4.2.3. Diarrhea Treatment
4.3. Global Opioids Market Attractiveness Index, By Therapeutic Application
5. Global Opioids Market, By Region
5.1. Introduction
5.1.1. Annual Growth Rate Comparison, By Region
5.1.2. BPS Analysis, By Region
5.2. Market Revenue (US$Mn) Forecast, By Region
5.2.1. North America
5.2.2. Latin America
5.2.3. Europe
5.2.4. Asia Pacific
5.2.5. Middle East
5.2.6. Africa
5.3. Global Opioids Market Attractiveness Index, By Region
6. North America Opioids Market Analysis and Forecast, 2019–2027
6.1. Introduction
6.1.1. Annual Growth Rate Comparison, By Country
6.1.2. BPS Analysis, By Country
6.2. Market Revenue (US$Mn) Forecast, By Country
6.2.1. U.S. Opioids Market
6.2.2. Canada Opioids Market
6.3. North America Opioids Market, By Product Type
6.3.1. Codeine
6.3.2. Fentanyl
6.3.3. Meperidine
6.3.4. Methadone
6.3.5. Morphine
6.3.6. Hydrocodone
6.4. North America Opioids Market, By Therapeutic Application
6.4.1. Pain Management
6.4.1.1. Neuropathic Pain
6.4.1.2. Migraine
6.4.1.3. Back Pain
6.4.1.4. Osteoarthritis Pain
6.4.1.5. Cancer Pain
6.4.1.6. Others
6.4.2. Cough Treatment
6.4.3. Diarrhea Treatment
6.5. North America Opioids Market Attractiveness Index
6.5.1. By Country
6.5.2. By Product Type
6.5.3. By Therapeutic Application
7. Latin America Opioids Market Analysis and Forecast, 2019–2027
7.1. Introduction
7.1.1. Annual Growth Rate Comparison, By Country
7.1.2. BPS Analysis, By Country
7.2. Market (US$Mn) Forecast, By Country
7.2.1. Brazil Opioids Market
7.2.2. Mexico Opioids Market
7.2.3. Argentina Opioids Market
7.2.4. Rest of Latin America Opioids Market
7.3. Latin America Opioids Market, By Product Type
7.3.1. Codeine
7.3.2. Fentanyl
7.3.3. Meperidine
7.3.4. Methadone
7.3.5. Morphine
7.3.6. Hydrocodone
7.4. Latin America Opioids Market, By Therapeutic Application
7.4.1. Pain Management
7.4.1.1. Neuropathic Pain
7.4.1.2. Migraine
7.4.1.3. Back Pain
7.4.1.4. Osteoarthritis Pain
7.4.1.5. Cancer Pain
7.4.1.6. Others
7.4.2. Cough Treatment
7.4.3. Diarrhea Treatment
7.5. Latin America Opioids Market Attractiveness Index
7.5.1. By Country
7.5.2. By Product Type
7.5.3. By Therapeutic Application
8. Europe Opioids Market Analysis and Forecast, 2019–2027
8.1. Introduction
8.1.1. Annual Growth Rate Comparison, By Country
8.1.2. BPS Analysis, By Country
8.2. Market (US$Mn) Forecast, By Country
8.2.1. U.K. Opioids Market
8.2.2. Germany Opioids Market
8.2.3. Italy Opioids Market
8.2.4. France Opioids Market
8.2.5. Spain Opioids Market
8.2.6. Russia Opioids Market
8.2.7. Poland Opioids Market
8.2.8. BENELUX Opioids Market
8.2.9. NORDIC Opioids Market
8.2.10. Rest of Europe Opioids Market
8.3. Europe Opioids Market, By Product Type
8.3.1. Codeine
8.3.2. Fentanyl
8.3.3. Meperidine
8.3.4. Methadone
8.3.5. Morphine
8.3.6. Hydrocodone
8.4. Europe Opioids Market, By Therapeutic Application
8.4.1. Pain Management
8.4.1.1. Neuropathic Pain
8.4.1.2. Migraine
8.4.1.3. Back Pain
8.4.1.4. Osteoarthritis Pain
8.4.1.5. Cancer Pain
8.4.1.6. Others
8.4.2. Cough Treatment
8.4.3. Diarrhea Treatment
8.5. Europe Opioids Market Attractiveness Index
8.5.1. By Country
8.5.2. By Product Type
8.5.3. By Therapeutic Application
9. Asia Pacific Opioids Market Analysis and Forecast, 2019–2027
9.1. Introduction
9.1.1. Annual Growth Rate Comparison, By Country
9.1.2. BPS Analysis, By Country
9.2. Market (US$Mn) Forecast, By Country
9.2.1. China Opioids Market
9.2.2. India Opioids Market
9.2.3. Japan Opioids Market
9.2.4. Australia and New Zealand Opioids Market
9.2.5. South Korea Opioids Market
9.2.6. ASEAN Opioids Market
9.2.7. Rest of Asia Pacific Opioids Market
9.3. Asia Pacific Opioids Market, By Product Type
9.3.1. Codeine
9.3.2. Fentanyl
9.3.3. Meperidine
9.3.4. Methadone
9.3.5. Morphine
9.3.6. Hydrocodone
9.4. Asia Pacific Opioids Market, By Therapeutic Application
9.4.1. Pain Management
9.4.1.1. Neuropathic Pain
9.4.1.2. Migraine
9.4.1.3. Back Pain
9.4.1.4. Osteoarthritis Pain
9.4.1.5. Cancer Pain
9.4.1.6. Others
9.4.2. Cough Treatment
9.4.3. Diarrhea Treatment
9.5. Asia Pacific Opioids Market Attractiveness Index
9.5.1. By Country
9.5.2. By Product Type
9.5.3. By Therapeutic Application
10. Middle East Opioids Market, By Region
10.1. Introduction
10.1.1. Annual Growth Rate Comparison, By Country
10.1.2. BPS Analysis, By Country
10.2. Market (US$Mn) Forecast, By Country
10.2.1. GCC Countries Opioids Market
10.2.2. Israel Opioids Market
10.2.3. Oman Opioids Market
10.2.4. Rest of Middle East Opioids Market
10.3. Middle East Opioids Market, By Product Type
10.3.1. Codeine
10.3.2. Fentanyl
10.3.3. Meperidine
10.3.4. Methadone
10.3.5. Morphine
10.3.6. Hydrocodone
10.4. Middle East Opioids Market, By Therapeutic Application
10.4.1. Pain Management
10.4.1.1. Neuropathic Pain
10.4.1.2. Migraine
10.4.1.3. Back Pain
10.4.1.4. Osteoarthritis Pain
10.4.1.5. Cancer Pain
10.4.1.6. Others
10.4.2. Cough Treatment
10.4.3. Diarrhea Treatment
10.5. Middle East Opioids Market Attractiveness Index
10.5.1. By Country
10.5.2. By Product Type
10.5.3. By Therapeutic Application
11. Africa Opioids Market, By Region
11.1. Introduction
11.1.1. Annual Growth Rate Comparison, By Country
11.1.2. BPS Analysis, By Country
11.2. Market (US$Mn) Forecast, By Country
11.2.1. South Africa Opioids Market
11.2.2. Egypt Opioids Market
11.2.3. North Africa Opioids Market
11.2.4. Rest of Africa Opioids Market
11.3. Africa Opioids Market, By Product Type
11.3.1. Codeine
11.3.2. Fentanyl
11.3.3. Meperidine
11.3.4. Methadone
11.3.5. Morphine
11.3.6. Hydrocodone
11.4. Africa Opioids Market, By Therapeutic Application
11.4.1. Pain Management
11.4.1.1. Neuropathic Pain
11.4.1.2. Migraine
11.4.1.3. Back Pain
11.4.1.4. Osteoarthritis Pain
11.4.1.5. Cancer Pain
11.4.1.6. Others
11.4.2. Cough Treatment
11.4.3. Diarrhea Treatment
11.5. Africa Opioids Market Attractiveness Index
11.5.1. By Country
11.5.2. By Product Type
11.5.3. By Therapeutic Application
12. Recommendation
12.1. Market Strategy
13. Competitive Landscape
13.1. Competition Dashboard
13.2. List and Company Overview of Global Key Players
13.3. Company Profiles
13.3.1. Pfizer Inc.
13.3.1.1. Company Overview
13.3.1.2. Financial Overview
13.3.1.3. Product Portfolio
13.3.1.4. Key Developments
13.3.1.5. Business Strategies
13.3.2. Purdue Pharma
13.3.3. Boehringer Ingelheim
13.3.4. Janssen Pharmaceuticals, Inc.
13.3.5. Actavis Plc.
13.3.6. Sanofi
13.3.7. Sun Pharmaceutical Industries Ltd.
13.3.8. Mallinckrodt Pharmaceuticals
13.3.9. Endo Pharmaceuticals Inc.
13.3.10. Egalet
14. Acronyms
Frequently Asked Questions
What is the projected market size & Compound Annual Growth Rate (CAGR) of the market?
The global opioids Market in 2020 is estimated for more than US$ 19.5 Bn and expected to reach a value of US$ 26.3 Bn by 2028 with a significant CAGR of 3.9%.
What are the key factors driving the growth of market?
The rapid need of treatment and attaining instant relief are the two major factors that are expected to favor the growth in the opioids market in the near future
What segments are covered in market report?
The global opioids market is segmented on the basis of product type, application type, and region
What are the key participating players in the market?
Pfizer Inc., Purdue Pharma, Boehringer Ingelheim, Janssen Pharmaceuticals, Inc., Actavis Plc., Sanofi, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Endo Pharmaceuticals Inc., and Egalet are the key participating players in the market
